CHPA, Congress propose dose of clarity for kids
HUNTINGTON, N.Y. — Concerns over kids’ medicines and proper dosing is still a prominent issue. Children between the ages of 2 years and 12 years are inaccurately dosed up to 73% of the time, according to a report published by the American Medical Association. This increases emergency room visits in two-thirds of the cases.
In January, N.Y. Rep. Steve Israel, D-Huntington, sparked debate over proper pediatric dosing when he announced plans to introduce new legislation to homogenize medicine cups and other dosage devices commonly used to give medicine to children. Israel cited a study published in the December 2010 Journal of the American Medical Association, which found that 99% of medicine cups and dosage devices were flawed, as the impetus behind the bill.
However, the need for such a bill may be moot as the over-the-counter industry is already initiating guidelines that will standardize dosing directions and units of measuring that dose by year’s end.
The Consumer Healthcare Products Association has approved voluntary guidelines, including the uniform use of tables to communicate dosing guidelines as opposed to only text, and the use of milliliters as the preferred unit for dosing with the abbreviation to read “mL.”
Allegra joins allergy aisle
PARIS — Allegra is less than a week away from reaching shelves on March 4, and with the latest allergy switch will come a significant number of Rx allergy sufferers this summer.
Though the allergy aisle is relatively saturated between Zyrtec, Claritin and private label, allergy consumers certainly are brand loyal, noted Laura Mahecha, Kline Group analyst. Mahecha suggested ongoing annual Allegra sales of between $100 million and $200 million without much cannibalization is realistic — and that’s great news for retailers who recorded almost $400 million in 2010 sales between Zyrtec and Claritin.
Cough-cold marketer opts for app
MOUNT KISCO, N.Y. — Prestige Brands became one of the first cough-cold marketers to develop a branded smart-phone app to help moms hone in on the most appropriate PediaCare remedy for their sick children. It’s not a bad play; a recent Millennial Media report indicated that in 2010, 32% of moms owned a smart phone, versus 20% in 2009.
The new PediaCare iPhone app coincides with the launch of PediaCare’s new, safe and effective cold-flu-fever medicines — with and without acetaminophen — that match the formulations of children’s Tylenol products that were recalled.